About this page
Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.
How to read it
- Form 4
- The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
- Buy (P) and Sell (S)
- Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
- Value
- Shares times price, as reported on the filing.
- 10b5-1
- A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
- Late filing
- A Form 4 filed more than two business days after the trade.
- Vs. S&P 500
- How the stock did after the trade minus how the overall market did in the same weeks.
A real example
In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.
Explain it like I'm 13
If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.
Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.
Alignment Healthcare, Inc. (ALHC): Insider Trades and Fund Holdings
In the past 12 months, Alignment Healthcare, Inc. insiders reported no open-market purchases and 15 sales worth $26.3M; 12 of the sales were reported as made under a 10b5-1 trading plan.
Timeline: news and trades
Company filings (8-K), insider trades, notices of planned sales (Form 144), Congress trades and fund moves in the past year, newest first.
- Oct 6, 2026Insider saleChief Medical Officer Hyong Kim sold $269,576
- Oct 5, 2026Planned saleHyong (Ken) Kim, M.D. (chief medical officer) filed notice to sell about $305,280 around Oct 6, 2026
- Sep 17, 2026Insider saleEVP Joseph S. Konowiecki sold $202,430
- Sep 16, 2026Planned saleJoseph Konowiecki (director / evp, corporate affairs) filed notice to sell about $226,460 around Sep 17, 2026
- Sep 14, 2026Insider saleCEO John E. Kao sold $356,200 under a 10b5-1 plan
- Sep 11, 2026Insider saleCEO John E. Kao sold $4.9 million under a 10b5-1 plan
- Sep 11, 2026Insider salePresident Dawn Christine Maroney sold $1.6 million
- Sep 10, 2026Insider saleCEO John E. Kao sold $2.2 million under a 10b5-1 plan
- Sep 10, 2026Planned saleJEK TRUST U/A DTD 02/08/2021 (director, officer) filed notice to sell about $6.5 million around Sep 10, 2026
- Sep 9, 2026Planned saleJohn Kao (chief executive officer / director) filed notice to sell about $5.3 million around Sep 10, 2026
- Sep 9, 2026Planned saleDawn C. Maroney (president) filed notice to sell about $1.7 million around Sep 10, 2026
- Aug 14, 2026Insider salePresident Dawn Christine Maroney sold $70,000 under a 10b5-1 plan
- Aug 14, 2026Planned saleDAWN MARONEY (officer) filed notice to sell about $67,300 around Aug 14, 2026
- Aug 10, 2026Insider saleCEO John E. Kao sold $4.1 million under a 10b5-1 plan
- Jul 30, 2026NewsCompany reported: Quarterly or annual results
- Jul 15, 2026Insider salePresident Dawn Christine Maroney sold $3.7 million under a 10b5-1 plan
- Jul 10, 2026Insider saleCEO John E. Kao sold $5.9 million under a 10b5-1 plan
- Jul 1, 2026Insider saleEVP Joseph S. Konowiecki sold $600,000 under a 10b5-1 plan
- Jun 30, 2026FundRenaissance Technologies cut 66% in Q2 2026 (13F filed Aug 13, 2026)
- Jun 26, 2026Insider saleEVP Joseph S. Konowiecki sold $575,000 under a 10b5-1 plan
- Jun 18, 2026Insider saleEVP Joseph S. Konowiecki sold $550,000 under a 10b5-1 plan
- Jun 15, 2026Insider salePresident Dawn Christine Maroney sold $586,425 under a 10b5-1 plan
- Jun 12, 2026Insider saleChief Medical Officer Hyong Kim sold $713,947 under a 10b5-1 plan
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 7, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Oct 7 | Hyong KimChief Medical Officer | ▼ SELL | $270K |
| Sep 18 | Joseph S. KonowieckiEVP | ▼ SELL | $202K |
| Sep 16 | John E. KaoCEO | ▼ SELL10b5-1 | $356K |
| Sep 11 | John E. KaoCEO | ▼ SELL10b5-1 | $4.89M |
| Sep 11 | John E. KaoCEO | ▼ SELL10b5-1 | $2.24M |
| Sep 11 | Dawn Christine MaroneyPresident | ▼ SELL | $1.56M |
| Aug 18 | Dawn Christine MaroneyPresident | ▼ SELL10b5-1 | $70K |
| Aug 10 | John E. KaoCEO | ▼ SELL10b5-1 | $4.14M |
| Jul 16 | Dawn Christine MaroneyPresident | ▼ SELL10b5-1 | $3.69M |
| Jul 14 | John E. KaoCEO | ▼ SELL10b5-1 | $5.92M |
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Hyong Kim | Chief Medical Officer | 0 | $0 | 2 | $984K |
| Joseph S. Konowiecki | EVP | 0 | $0 | 4 | $1.93M |
| John E. Kao | CEO | 0 | $0 | 5 | $17.5M |
| Dawn Christine Maroney | President | 0 | $0 | 4 | $5.90M |
Buybacks and executive pay
| Year | CEO pay reported | CEO pay "actually paid" | Value of $100 invested |
|---|---|---|---|
| 2025 | $11.3M | $52.3M | n/a |
| 2024 | $6.37M | $25.2M | n/a |
| 2023 | $14.3M | −$2.67M | n/a |
From the company's XBRL data filed with the SEC. "Actually paid" is the SEC's pay-versus-performance measure, which counts changes in the value of stock awards. "Value of $100 invested" is the company's cumulative shareholder return as reported, usually measured from five years earlier. See all buybacks and CEO pay across companies.
A All 15 insider trades reported on time. How it is graded
Tracked funds that report ALHC
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Renaissance Technologies | 998,400 | $23.8M | ▼ −65.6% |
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →